Day: January 26, 2022

LAS VEGAS, Jan. 26, 2022 (GLOBE NEWSWIRE) — Marathon Digital Holdings, Inc. (NASDAQ:MARA) (“Marathon” or “Company”), one of the largest enterprise Bitcoin self-mining companies in North America, today announced that the Company has appointed Ashu Swami as chief technology officer. Swami will be responsible for overseeing and expanding the Company’s technical operations, ensuring rigorous security measures are met across the organization, and providing technical guidance. Swami is an experienced chip designer and crypto and DeFi expert, who brings to Marathon deep technical, regulatory, and market expertise. Swami joins Marathon Digital Holdings from Core Scientific, where he served as the chief product officer, leading the company’s foray into DeFi and heading mining hardware and software optimization. Prior...

CHATTANOOGA, Tenn., Jan. 26, 2022 (GLOBE NEWSWIRE) — Covenant Logistics Group, Inc. (NASDAQ/GS: CVLG) (“Covenant” or the “Company”) announced today financial and operating results for the fourth quarter ended December 31, 2021. Additionally, the Company announced that it will initiate a quarterly cash dividend of $0.0625 per share in the first quarter of 2022. The Company’s live conference call to discuss the quarter will be held at 10:00 A.M. Eastern Time on Thursday, January 27, 2022. Chairman and Chief Executive Officer, David R. Parker, commented: “We are pleased to report fourth quarter earnings of $1.05 per diluted share and non-GAAP adjusted earnings of $1.07 per diluted share (1). For 2021, we generated over $1 billion in revenue, the highest annual earnings per share in our history, and a 13% return on average invested...

Reaffirms FY 2021 Guidance and Announces Earnings Release Date ANDOVER, Mass., Jan. 26, 2022 (GLOBE NEWSWIRE) — Casa Systems, Inc. (Nasdaq: CASA), a leading provider of physical and cloud-native infrastructure technology solutions for wireless, cable and fixed broadband networks, today announced that Scott Bruckner will be resigning as Chief Financial Officer (“CFO”) of the Company, effective April 3, 2022, to attend to family issues. The Company also reaffirmed its full year guidance and announced the date of its fourth quarter earnings call. Mr. Bruckner’s departure is not based on any disagreement with or irregularities in the Company’s accounting principles, practices or financial statement disclosures. Casa Systems has already initiated a search for Mr. Bruckner’s successor. Mr. Bruckner will take an active role in this process...

Net Income of $28.5 million, EPS of $0.37 BOSTON, Jan. 26, 2022 (GLOBE NEWSWIRE) — Brookline Bancorp, Inc. (NASDAQ: BRKL) (the “Company”) today announced net income of $28.5 million, or $0.37 per basic and diluted share, for the fourth quarter of 2021, compared to $28.8 million, or $0.37 per basic and diluted share, for the third quarter of 2021, and $26.7 million, or $0.34 per basic and diluted share, for the fourth quarter of 2020. For the year ended December 31, 2021, the Company reported record net income of $115.4 million, or $1.48 per basic and diluted share. This compared to $47.6 million, or $0.60 per basic and diluted share, for the year ended December 31, 2020. Paul Perrault, Chairman and Chief Executive Officer commented on the Company’s performance, “I am pleased with our strong financial performance and earnings growth...

HOUSTON, Jan. 26, 2022 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that Rick Fair, President and CEO, will participate in the B. Riley Securities 2022 Virtual Oncology Conference. A corporate presentation is scheduled for Thursday, January 27, 2022 at 4 p.m. ET / 1 p.m. PT. A live webcast of the presentation will be available from the Investor Relations section of the company website at Events & Presentations – Bellicum with a replay available shortly after the live event. About Bellicum Pharmaceuticals Bellicum is a clinical stage biopharmaceutical company striving to deliver cures through controllable cell therapies. The company’s next-generation product candidates are differentiated by powerful cell...

CHARLESTON, S.C., Jan. 26, 2022 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) has notified the Company that it has been granted an additional 180 calendar day period, through July 23, 2022, to evidence compliance with the US$1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market. If at any time before July 23, 2022, the bid price for the Company’s common shares closes at or above US$1.00 per share for a minimum of 10 consecutive business days (and generally not more than 20 consecutive business days,...

FREMONT, Calif., Jan. 26, 2022 (GLOBE NEWSWIRE) — Lam Research Corporation (the “Company,” “Lam,” “Lam Research”) today announced financial results for the quarter ended December 26, 2021 (the “December 2021 quarter”). Highlights for the December 2021 quarter were as follows:Revenue of $4.23 billion. U.S. GAAP gross margin of 46.8%, U.S. GAAP operating income as a percentage of revenue of 31.7%, and U.S. GAAP diluted EPS of $8.44. Non-GAAP gross margin of 46.8%, non-GAAP operating income as a percentage of revenue of 32.0%, and non-GAAP diluted EPS of $8.53.Key Financial Data for the Quarters Ended December 26, 2021 and September 26, 2021 (in thousands, except per-share data, percentages, and basis points) U.S. GAAP    December 2021   September 2021   Change Q/QRevenue   $ 4,226,604     $ 4,304,465     –...

OAK BROOK, Ill., Jan. 26, 2022 (GLOBE NEWSWIRE) — Hub Group, Inc. (Nasdaq: HUBG) will hold a conference call at 5:00 p.m. Eastern Time on Tuesday, February 8, 2022 to discuss its fourth quarter 2021 results. The results will be announced via press release after the market closes on the day of the call. This call is being webcast and can be accessed through the Investors link on Hub Group’s web site at www.hubgroup.com. The webcast is listen-only. Those interested in participating in the question-and-answer session should follow the telephone dial-in instructions below. To participate in the conference call by telephone, please register at https://www.yourconferencecenter.com/confcenter/PinCode/Pin_Code.aspx?100374&o=UcNaSJujBcPGSa. Registrants will be issued a passcode and PIN to use when dialing into the live call which will...

Succeeds current Chief Executive Officer and co-founder Onno van de Stolpe, following planned retirement Recognized as inspirational industry leader with exceptional R&D as well as global executive experience, and a strong focus on bringing innovative medicines to patients Outstanding track record of accelerated product development in biotech and pharma through insightful acquisitions and strategic partnershipsMechelen, Belgium; 26 January 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) is pleased to announce the appointment of Dr. Paul Stoffels as Chief Executive Officer (CEO), effective April 1, 2022. Dr. Stoffels brings an impressive track record of success in innovative drug discovery and development, and a wealth of experience in biotech and pharma, across a range of roles and therapeutic...

SUNNY ISLES BEACH, Fla., Jan. 26, 2022 (GLOBE NEWSWIRE) — IEP Utility Holdings LLC, an affiliate of Icahn Enterprises L.P. (the “Offeror”), announced that it has extended the expiration date of its tender offer (the “Offer”) to purchase any and all of the issued and outstanding shares of the common stock, par value $1.00 per share (the “Common Stock”), of Southwest Gas Holdings, Inc., a Delaware corporation (the “Company” or “Southwest Gas”), including the associated rights issued pursuant to the Rights Agreement, dated October 10, 2021 (as it may be amended from time to time, the “Rights Agreement”), between the Company and Equiniti Trust Company, as rights agent, that are issued and outstanding (the “Rights” and, together with the Common Stock, the “Shares”), for $75.00 per Share in cash, without interest, less any applicable...